TRα positivity was associated with significantly reduced five-year survival in BRCA1 carriers (p = 0.030) (Fig 4A), while no effect of TRα on patient survival was observed in sporadic cancer cases (Fig 4B). This evidence concerns the gene BRCA1 and cancer.